Therapeutic recombinant Hepatitis B virus vaccine (Jiangsu Recbio Technology)

治疗用重组乙型肝炎病毒疫苗（江苏瑞科生物）

Report date: 2025/12/11 09:42:38

Base Information

Drug NameTherapeutic recombinant Hepatitis B virus vaccine (Jiangsu Recbio Technology)

Drug Alias NameREC-630

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesJiangsu Rec-Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Rec-Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsHepatitis B

Inactive IndicationsN/A

Other Information

ATC CodeN/A